TopMarketGainers

Galectin Therapeutics a buy on break above 200MA

NASDAQ:GALT   GALECTIN THERAPEUTICS INC
Very bullish action in the stock which has been stalled by the 200MA acting as strong resistance.
A break above could see a nice bull run to FIB Resistance @ $5.
Indicator bullish .

Average analysts price target $11
Average analysts recommendation BUY
Short interest 8.47%
Company profile
Galectin Therapeutics , Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs targets the development of carbohdrate molecules which offers offer alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA
Do you want to GAIN an Edge on Wall Street?

1) Sign Up for our Free Email Newsletter @
http://www.TopMarketGainers.com

2) Sign Up for our Free Text Message Notifications
by Texting 'GAINS' to 67076.

(*It's FREE, however Msg&Data rates may apply
Home Stock Screener Forex Screener Crypto Screener Economic Calendar How It Works Chart Features Pricing House Rules Moderators Website & Broker Solutions Widgets Charting Solutions Help Center Feature Request Blog & News FAQ Wiki Twitter
Profile Profile Settings Account and Billing TradingView Coins My Support Tickets Help Center Ideas Published Followers Following Private Messages Chat Sign Out